Intrinsic Value of S&P & Nasdaq Contact Us

Versartis, Inc. VSAR NASDAQ

NASDAQ • Healthcare • Biotechnology • USD

SharesGrow Score
51/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Versartis, Inc. (VSAR) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 48/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
51/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
46/100
→ Income
GROWTH
100/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — VSAR

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio3.76
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.21
Book Value / Share$0.00
Revenue / Share$0.32
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2014 $-3.04 $0.00 $-57.51M -
2015 $-2.84 $0.00 $-82.18M -
2016 $-3.11 $0.00 $-95.82M -
2017 $-2.41 $40M $-84.98M -212.4%
2018 $-10.64 $1.37M $-76.33M -5567.7%
2019 $-1.21 $4.75M $-18.22M -383.3%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message